Target intelligence / Profile preview

Amyloid beta precursor protein binding family B member 1 (APBB1)

Target
APBB1
Molecular classification
Other (Adaptor protein)
01

Overview

Amyloid beta precursor protein binding family B member 1 (APBB1, also known as FE65) is a nuclear-localized adaptor protein of the Fe65 protein family. It interacts directly with the cytoplasmic tail of amyloid precursor protein (APP) and is involved in the transcriptional regulation of genes, modulation of apoptosis, and cell cycle progression. APBB1 is proposed to play an important role in Alzheimer’s disease pathogenesis due to its association with APP and effects on amyloid processing and nuclear signaling. It is also implicated in learning, memory, and the maintenance of neuronal and muscle functions[1][2][3][11]. Multiple alternatively spliced isoforms exist, with some differences in their nuclear signaling potential. APBB1 interacts with various partners including APP, APLP2, transcription factor CP2/LSF/LBP1, and LRP1, supporting its role as a key signal integration molecule in the central nervous system[1][3][8][11].

Other names
FE65RIRProtein Fe65FE65a2Amyloid-beta A4 precursor protein-binding family B member 1adaptor protein FE65stat-like protein
02

Mechanism of action

null (adapter protein; drugs modulating APP processing may be indirectly relevant, but no direct targeting mechanism described)

03

Biological functions

Transcription regulation (coregulator: coactivator/corepressor)Apoptosis inductionCell cycle progression blockadeNeurite outgrowthNuclear translocationChromatin binding/histone recognition
04

Disease associations

Neurodegenerative disease (notably Alzheimer’s disease)Cognitive disorders (learning and memory impairment)Niemann-Pick disease (type A and B associations)
05

Safety considerations

no direct therapeutic safety concerns are described for targeting APBB1; as an adaptor, broad roles in neuronal function could make it a challenging target

Beyond the preview

Go deeper on Amyloid beta precursor protein binding family B member 1 (APBB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid beta precursor protein binding family B member 1 (APBB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call